iNtRON Biotechnology, Inc. (KOSDAQ:048530)
2,795.00
+5.00 (0.18%)
Nov 2, 2026, 3:30 PM KST
| Market Cap | 86.34B -17.7% |
| Revenue (ttm) | 5.74B -10.6% |
| Net Income | -8.96B |
| EPS | -282.94 |
| Shares Out | 30.89M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 100.00 (3.58%) |
| Ex-Dividend Date | n/a |
| Volume | 72,725 |
| Open | 2,790.00 |
| Previous Close | 2,790.00 |
| Day's Range | 2,720.00 - 2,840.00 |
| 52-Week Range | 2,250.00 - 7,010.00 |
| Beta | 0.15 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |